NO142024C - Fremgangsmaate for fremstilling av en vaksine, saerlig influensavaksine, ved aa dyrke et virus - Google Patents
Fremgangsmaate for fremstilling av en vaksine, saerlig influensavaksine, ved aa dyrke et virusInfo
- Publication number
- NO142024C NO142024C NO743758A NO743758A NO142024C NO 142024 C NO142024 C NO 142024C NO 743758 A NO743758 A NO 743758A NO 743758 A NO743758 A NO 743758A NO 142024 C NO142024 C NO 142024C
- Authority
- NO
- Norway
- Prior art keywords
- vaccine
- virus
- culture
- procedure
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB48685/73A GB1486557A (en) | 1973-10-18 | 1973-10-18 | Process for the preparation of pyrogen-free sub-unit vaccine |
Publications (3)
Publication Number | Publication Date |
---|---|
NO743758L NO743758L (US20100268047A1-20101021-C00003.png) | 1975-05-12 |
NO142024B NO142024B (no) | 1980-03-10 |
NO142024C true NO142024C (no) | 1980-06-18 |
Family
ID=10449549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO743758A NO142024C (no) | 1973-10-18 | 1974-10-17 | Fremgangsmaate for fremstilling av en vaksine, saerlig influensavaksine, ved aa dyrke et virus |
Country Status (15)
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK276380A (da) * | 1979-07-09 | 1981-01-10 | Univ Iowa State Res Found Inc | Fremgangsmaade til fremstilling af en vaccine mod infektioes kvaeg-rhinotracheitis |
FR2470795A1 (fr) * | 1979-12-07 | 1981-06-12 | Pasteur Institut | Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus |
FR2475572A1 (fr) * | 1980-02-11 | 1981-08-14 | Pasteur Institut | Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications |
FR2483779A1 (fr) | 1980-06-05 | 1981-12-11 | Synthelabo | Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins |
DE19938767C2 (de) * | 1999-08-16 | 2002-10-24 | Tad Pharma Gmbh | Spaltimpfstoffe |
JP2004510747A (ja) * | 2000-10-02 | 2004-04-08 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 分割エンベロープウイルス調製物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3519400A (en) * | 1967-01-25 | 1970-07-07 | Atomic Energy Commission | Method of centrifugal separation and recovery of chemical species utilizing a liquid medium |
-
1973
- 1973-10-18 GB GB48685/73A patent/GB1486557A/en not_active Expired
-
1974
- 1974-10-08 ZA ZA00746398A patent/ZA746398B/xx unknown
- 1974-10-17 NO NO743758A patent/NO142024C/no unknown
- 1974-10-17 DK DK543974AA patent/DK138581B/da not_active IP Right Cessation
- 1974-10-17 IE IE2141/74A patent/IE40187B1/xx unknown
- 1974-10-17 CH CH1394974A patent/CH611518A5/xx not_active IP Right Cessation
- 1974-10-17 SE SE7413113A patent/SE426439B/xx unknown
- 1974-10-17 JP JP49119836A patent/JPS5082228A/ja active Pending
- 1974-10-17 DE DE2449530A patent/DE2449530C2/de not_active Expired
- 1974-10-17 BE BE149618A patent/BE821175A/xx not_active IP Right Cessation
- 1974-10-17 NL NLAANVRAGE7413642,A patent/NL181553C/xx not_active IP Right Cessation
- 1974-10-17 AT AT835074A patent/AT334524B/de not_active IP Right Cessation
- 1974-10-17 CA CA211,654A patent/CA1050886A/en not_active Expired
- 1974-10-17 IL IL45870A patent/IL45870A/xx unknown
- 1974-10-18 FR FR7435179A patent/FR2248054B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
AU7444974A (en) | 1976-04-29 |
IL45870A (en) | 1978-03-10 |
NL181553B (nl) | 1987-04-16 |
DE2449530C2 (de) | 1985-08-08 |
DE2449530A1 (de) | 1975-04-30 |
ZA746398B (en) | 1976-06-30 |
SE426439B (sv) | 1983-01-24 |
IL45870A0 (en) | 1974-12-31 |
NL7413642A (nl) | 1975-04-22 |
DK138581C (US20100268047A1-20101021-C00003.png) | 1979-03-12 |
CH611518A5 (en) | 1979-06-15 |
GB1486557A (en) | 1977-09-21 |
NO743758L (US20100268047A1-20101021-C00003.png) | 1975-05-12 |
CA1050886A (en) | 1979-03-20 |
IE40187L (en) | 1975-04-18 |
DK543974A (US20100268047A1-20101021-C00003.png) | 1975-06-16 |
FR2248054A1 (US20100268047A1-20101021-C00003.png) | 1975-05-16 |
DK138581B (da) | 1978-10-02 |
FR2248054B1 (US20100268047A1-20101021-C00003.png) | 1978-07-28 |
IE40187B1 (en) | 1979-03-28 |
NO142024B (no) | 1980-03-10 |
ATA835074A (de) | 1976-05-15 |
BE821175A (fr) | 1975-04-17 |
NL181553C (nl) | 1987-09-16 |
SE7413113L (US20100268047A1-20101021-C00003.png) | 1975-04-21 |
JPS5082228A (US20100268047A1-20101021-C00003.png) | 1975-07-03 |
AT334524B (de) | 1976-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO143940C (no) | Fremgangsmaate ved fremstilling av alfa-l-aspartyl-l-fenyl-alaninalkylestere | |
OA04704A (fr) | Procédé de préparation de nouveaux vaccins. | |
RO69182A (ro) | Procedeu pentru prepararea unor aciloxi-aldehide | |
RO69607A (ro) | Procedeu pentru prepararea unor 3-carbamoiloximetilcefalosporine | |
NO142894C (no) | Fremgangsmaate ved fremstilling av polyethylenterefthalatfilm | |
SE419750B (sv) | Forfarande for framstellning av 6-acyl-2,4-dialkyl-2-hydroxicyklohexan-1,35-trion | |
NO740670L (no) | Analogifremgangsmåte for fremstilling av nye 1-aryloksy-2-hydroksy-3-alkynylaminopropanforbindelser. | |
NO741223L (no) | Fremgangsmåte for fremstilling av 6-deoksytetracykliner. | |
DK143437C (da) | Fremgangsmaade til fremstilling af en vaccine til hindring af sygdomme fremkaldt af katteleukaemivirus | |
NO142024C (no) | Fremgangsmaate for fremstilling av en vaksine, saerlig influensavaksine, ved aa dyrke et virus | |
SE387341B (sv) | Forfarande for framstellning av 1-aryl-n-dialkyl-aminoalkyl-3,4-dihydro2(h)-isokinolinkarboxamider | |
SE421313B (sv) | Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler | |
DK131633B (da) | Fremgangsmåde til fremstilling af 3-(17beta-4-androsten-3-on-17beta-yl)-propiolacton. | |
RO69264A (ro) | Procedeu pentru prepararea alfa-amino-alcoolilor | |
NO741133L (no) | Fremgangsmåte for fremstilling av metyl-3-(2-kinoksalinylmetylen)-karbazat-N1.N4-dioksyd. | |
SE401835B (sv) | Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on | |
CH611338A5 (en) | Process for the preparation of inactivated HB-Ag vaccines | |
DK140411B (da) | Fremgangsmåde til fremstilling af deacetoxycephalosporin C. | |
RO72838A (ro) | Procedeu de preparare a 3-(2-fluor-4-bifenilil)-1-butanol | |
NO741141L (no) | Analogifremgangsmåte ved fremstilling av nye terapeutisk aktive benzopyranopyridinderivater. | |
RO65994A (ro) | Procedeu pentru prepararea unor diaminobenzofenone | |
NO140297C (no) | Fremgangsmaate ved fremstilling av alfa1-t-butylaminomethyl-4-hydroxy-m-xylen-alfa1,alfa3-diol | |
NO139558C (no) | Fremgangsmaate ved fremstilling av n-(2-amino-3,5-dibrombenzyl)-n-metylcykloheksylamin | |
SE396212B (sv) | Forfarande for framstellning av ett alkalimetallditionit | |
NO740744L (no) | Fremgangsmåte til fremstilling av oksiranforbindelser. |